Centessa Pharmaceuticals PLC
CNTA
Company Profile
Business description
Centessa Pharmaceuticals PLC is a clinical-stage pharmaceutical company. The company's pipeline assets include: SerpinPC for Hemophilia A, B; LB101 for Solid Tumors; ORX750 for Narcolepsy Type 1 (NT1) and other sleep disorders; MGX292 Pulmonary Arterial Hypertension (PAH); and Undisclosed for Solid Tumors.
Contact
1 Ashley Road
3rd Floor
Altrincham
CheshireWA14 2DT
GBRSector
Healthcare
Stock type
Defensive
Industry
Biotechnology
Fiscal Year End
31 December 2025
Employees
114
Stocks News & Analysis
stocks
Picking dividend shares in 2026? Here’s where to look
A new report from Morningstar shows opportunities for income investors.
stocks
Ahead of earnings, is Nvidia a buy, a sell, or fairly valued?
With outstanding long-term estimates, here’s what we think of Nvidia stock.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 8,834.00 | 88.40 | 1.01% |
| CAC 40 | 8,020.67 | 66.90 | 0.84% |
| DAX 40 | 23,417.50 | 254.58 | 1.10% |
| Dow JONES (US) | 46,138.77 | 47.03 | 0.10% |
| FTSE 100 | 9,567.87 | 60.46 | 0.64% |
| HKSE | 25,835.57 | 4.92 | 0.02% |
| NASDAQ | 22,564.23 | 131.38 | 0.59% |
| Nikkei 225 | 49,823.94 | 1,286.24 | 2.65% |
| NZX 50 Index | 13,439.40 | 112.50 | 0.84% |
| S&P 500 | 6,642.16 | 24.84 | 0.38% |
| S&P/ASX 200 | 8,552.70 | 84.70 | 1.00% |
| SSE Composite Index | 3,931.05 | 15.69 | -0.40% |